Newron Pharmaceuticals S.p.A. (NWPHF)
OTCMKTS · Delayed Price · Currency is USD
12.00
+0.60 (5.26%)
May 15, 2024, 8:30 AM EST
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of $506.96 million as of February 12, 2026. Its market cap has increased by 149.78% in one year.
Market Cap
506.96M
Enterprise Value
518.34M
Revenue
70.32M
Ranking
n/a
PE Ratio
17.04
Stock Price
$12.00
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 257.00M to 506.96M, an increase of 97.26%. That is a compound annual growth rate of 3.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 506.96M | -15.81% |
| Dec 30, 2025 | 602.17M | 213.61% |
| Dec 30, 2024 | 192.01M | 83.04% |
| Dec 29, 2023 | 104.90M | 250.69% |
| Dec 30, 2022 | 29.91M | -5.41% |
| Dec 30, 2021 | 31.62M | -27.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 141.56M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |